by Clevertar | Sep 28, 2020 | Artificial Intelligence, News
If you have, then maybe you or your team are fed up answering questions like, “Do I need a form for this?’ I must admit, answering questions like that would be annoying.
by Clevertar | Sep 11, 2020 | Artificial Intelligence, News
Our team at Clevertar has just put the finishing touches on a service upgrade that will make our 3D virtual agents much faster and more capable at handling large volumes of traffic.
by Clevertar | Aug 31, 2020 | Artificial Intelligence, News
Our team created a virtual interviewer called ‘Sophia’ to ask candidates questions to help qualify, vet and recommend them for interview.
by Clevertar | Aug 27, 2020 | Artificial Intelligence, News
We’ve put together a list of cornerstones to help you get CX right amid the pandemic, because you can pleasantly surprise stressed-out users and customers.
by Clevertar | Aug 4, 2020 | Artificial Intelligence, News
Working from home, our team achieves the same outcomes as they previously did, while they enjoy zero commute time and the opportunity for personal concentration that can’t be achieved in an open-plan office.
by Clevertar | Jul 29, 2020 | Artificial Intelligence, News
Zoe is a chatbot that we built and launched in six days to help SA Health respond to a surge in COVID-19-related queries.
by Clevertar | Jul 27, 2020 | Artificial Intelligence, News
CMO has named Clevertar’s COVID-19 virtual agent launched by SA Health as one of the top innovative chatbots in 2020.
by Clevertar | Jul 17, 2020 | Artificial Intelligence, News
Clevertar’s Tanya Newhouse (CEO), and Matt Francis (Solutions Lead), recently appeared on the ‘Let’s Be Mates’ Podcast created by MATE.
by Clevertar | Jul 16, 2020 | Artificial Intelligence, News
Clevertar has helped Maven deploy their newest team member ‘May’, who was designed to help businesses quickly and simply evaluate their accessibility and inclusion practices.
by Clevertar | Apr 28, 2020 | Artificial Intelligence, News
South Australians can now access instant and authoritative answers to their COVID-19 queries.